NVCA Announces HistoSonics as 2025 Startup Innovator

WASHINGTON, DC – The National Venture Capital Association (NVCA) is proud to announce HistoSonics as the winner of its 2025 Startup Innovator award.

“HistoSonics is a shining example of the entrepreneurial ecosystem at its best,” said NVCA President and CEO Bobby Franklin. “It all started with groundbreaking research at the University of Michigan, followed by dedicated entrepreneurs and investors working together to bring that innovation to market. In collaboration with government medical and regulatory agencies, this incredible technology is now transforming tumor treatment—offering patients a way to fight the disease without the harsh side effects of traditional methods. By changing the paradigm of health care with this cutting edge technology, HistoSonics is making a profound impact on both science and society, and we are proud to name them our 2025 NVCA Startup Champion.”

NVCA will celebrate HistoSonics at the 2025 NVCA Leadership Awards Dinner. The event will take place on June 5, 2025, at the Rosewood Hotel in Menlo Park, CA. Registration is required. 

###

The National Venture Capital Association (NVCA) empowers the next generation of American companies that will fuel the economy of tomorrow. As the voice of the U.S. venture capital and startup community, NVCA advocates for public policy that supports the American entrepreneurial ecosystem. Serving the venture community as the preeminent trade association, NVCA arms the venture community for success, serving as the leading resource for venture capital data, practical education, peer-led initiatives, and networking. For more information about NVCA, please visit www.nvca.org.